Phase II results shows promise for Type 1 diabetes drug

被引：0

|

作者：

Patience, Jonny

机构：

来源：

EXPERT REVIEW OF CLINICAL IMMUNOLOGY | 2013年 / 9卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

收藏

页码：896 / 897

页数：2

相关论文

共 50 条

[21] Class II peptide multimers: promise for type 1A diabetes?
Eisenbarth, GS
Nepom, GT
NATURE IMMUNOLOGY, 2002, 3 (04) : 344 - 345
[22] Class II peptide multimers: promise for type 1A diabetes?
George S. Eisenbarth
Gerald T. Nepom
Nature Immunology, 2002, 3 : 344 - 345
[23] New combination therapy shows promise for recent-onset type 1 diabetes mellitus
Starling, Shimona
NATURE REVIEWS ENDOCRINOLOGY, 2021, 17 (05) : 257 - 257
[24] New combination therapy shows promise for recent-onset type 1 diabetes mellitus
Shimona Starling
Nature Reviews Endocrinology, 2021, 17 : 257 - 257
[25] SGLT2 inhibitor shows promise in type 2 diabetes
Nature Reviews Drug Discovery, 2010, 9 (3) : 182 - 182
[26] Vildagliptin shows promise for the treatment of patients with advanced type 2 diabetes
不详
Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 (9): : 621 - 621
[27] Anti-PD-1 Drug Shows Strong Promise
不详
CANCER DISCOVERY, 2012, 2 (07)
[28] Gene therapy for Parkinson disease shows promise in phase II trial
Katie Kingwell
Nature Reviews Neurology, 2011, 7 (5) : 241 - 241
[29] Opioid receptor blocker shows promise in Phase II depression trial
Harrison, Charlotte
NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (06) : 415 - 415
[30] NEURODEGENERATIVE DISEASE Novel ALS therapy shows promise in Phase II
Crunkhorn, Sarah
NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (01) : 22 - 22

← 1 2 3 4 5 →